Goncalves Suzana Cristina, de Moraes Siqueira Rafael, Nogueira Marcus Vinicius F, Pereira-Correia Joao Antonio, Vaz Fernando Pires, Peres Wilza Arantes Ferreira
Department of Nutritional Biochemistry, Faculty of Nutrition, Federal University of Rio de Janeiro, Avenida Carlos Chagas Filho 373, Ilha do Fundao, Rio de Janeiro, RJ, Brazil.
Department of Urology, Servidores do Estado Federal Hospital, Rua Sacadura Cabral 120, Saude, Rio de Janeiro, RJ, Brazil.
World J Oncol. 2013 Apr;4(2):87-94. doi: 10.4021/wjon664e. Epub 2013 May 6.
The relationship between hyperglycemia and prostate cancer remains controversial. According to current hypotheses, elevated serum glucose levels may lead to disease development or disease prevention. Our study examined the potential correlation between pre-operative glycemic levels of patients with prostate cancer and the grade of tumor aggressiveness.
We studied the case files of patients with a diagnosis of prostate cancer who had received putatively curative cancer surgery at the Urology Department of the Servidores do Estado Federal Hospital (RJ/Brazil). We transcribed information related to glycemia - collected up to 3 months before the surgery - and the histopathological grade of tumor aggressiveness (Gleason score) of the surgically removed prostates.
We analyzed 42 people who met the inclusion criteria. Based on Gleason scores, among the normoglycemic patients, we detected low, moderate, and highly aggressive neoplasias in 13%, 53%, and 36% of the cases, respectively. For the hyperglycemic group, these rates were 30%, 60%, and 10%, respectively. Normoglycemic patients had primary Gleason grade 3 in 40% of the cases and grade 4 in 60% of the cases. For the hyperglycemic patients, these rates were 90% and 10%, respectively (P < 0.05 vs. grade 3 group).
Both Gleason score and primary Gleason grade were lower in hyperglycemic patients with prostate cancer than in normoglycemic patients, suggesting a "protective action" of hyperglycemic states.
高血糖与前列腺癌之间的关系仍存在争议。根据目前的假说,血清葡萄糖水平升高可能导致疾病发展或预防疾病。我们的研究探讨了前列腺癌患者术前血糖水平与肿瘤侵袭性分级之间的潜在相关性。
我们研究了在巴西里约热内卢联邦政府医院泌尿外科接受根治性癌症手术的前列腺癌患者的病历。我们记录了与血糖相关的信息(手术前3个月内收集)以及手术切除前列腺的肿瘤侵袭性组织病理学分级( Gleason评分)。
我们分析了42名符合纳入标准的患者。根据Gleason评分,在血糖正常的患者中,分别有13%、53%和36%的病例检测到低、中和高侵袭性肿瘤。对于高血糖组,这些比例分别为30%、60%和10%。血糖正常的患者中,40%的病例主要Gleason分级为3级,60%的病例为4级。对于高血糖患者,这些比例分别为90%和10%(与3级组相比,P < 0.05)。
前列腺癌高血糖患者的Gleason评分和主要Gleason分级均低于血糖正常患者,提示高血糖状态具有“保护作用”。